The genetics of IgA deficiency : a ‛two-disease’ approach

Selective IgA deficiency (IgAD) is the most common primary immunodeficiency disorder in Caucasians with a prevalence of approximately 1:600 in the general population. It is defined as serum IgA levels below or equal to 0.07 g/l with normal serum levels of IgM and IgG above the age of 4. Most IgAD in...

Full description

Bibliographic Details
Main Author: Wang, Ning
Format: Doctoral or Postdoctoral Thesis
Language:English
Published: Inst för laboratoriemedicin / Dept of Laboratory Medicine 2015
Subjects:
Online Access:http://hdl.handle.net/10616/41823
Description
Summary:Selective IgA deficiency (IgAD) is the most common primary immunodeficiency disorder in Caucasians with a prevalence of approximately 1:600 in the general population. It is defined as serum IgA levels below or equal to 0.07 g/l with normal serum levels of IgM and IgG above the age of 4. Most IgAD individuals are asymptomatic, however, one-third suffer from respiratory and gastrointestinal infections and concomitant autoimmune diseases. IgAD is associated with several classical autoimmune disorders including Graves’ disease (GD), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), celiac disease (CD) and potentially rheumatoid arthritis and myasthenia gravis (MG). As more than 95% of patients with GD are positive for thyrotropin-receptor autoantibody (TRAb), we thus investigated the prevalence of IgAD in TRAb-seropositive individuals both in Sweden and Iceland and showed that the prevalence of IgAD in the Swedish cohort is significantly higher than expected in the general population. TRAb- seropositivity is also common among IgAD individuals in both cohorts, suggesting a predisposition to GD (Paper I). There is a markedly increased prevalence of IgAD among adults with CD. It is therefore important to validate the IgG class antibody tests for screening CD in IgAD adults. IgG anti tissue transglutaminase (anti-tTG) and anti deamidated gliadin peptides (anti-DGP) antibodies were determined in our IgAD cohort with suspected CD. IgG anti-tTG seems to be a reliable marker for CD in IgAD adults whereas the diagnostic specificity of IgG anti-DGP appears to be lower. We also found that high levels of IgG antibodies against both tTG and DGP were frequently found in IgAD adults despite adhering to a gluten free diet (Paper II). We subsequently screened IgAD among patients with SLE and T1D in different ethnical populations and the observed higher prevalence of IgAD was consistent with previous publications (Paper III). IgAD is reported to be strongly associated with the MHC region, especially the HLA- A1, B8, DR3, DQ2 ...